Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
25.90
-1.64 (-5.95%)
At close: Jul 20, 2026, 4:00 PM EDT
25.80
-0.10 (-0.39%)
After-hours: Jul 20, 2026, 7:57 PM EDT
Alto Neuroscience Employees
Alto Neuroscience had 68 employees as of December 31, 2025. The number of employees decreased by 8 or -10.53% compared to the previous year.
Employees
68
Change (1Y)
-8
Growth (1Y)
-10.53%
Revenue / Employee
n/a
Profits / Employee
-$1,092,735
Market Cap
1.01B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | -8 | -10.53% |
| Dec 31, 2024 | 76 | 9 | 13.43% |
| Sep 30, 2024 | 88 | 27 | 44.26% |
| Jun 30, 2024 | 78 | 17 | 27.87% |
| Mar 31, 2024 | 67 | - | - |
| Sep 30, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 409 |
| Wave Life Sciences | 317 |
| Capricor Therapeutics | 231 |
| EyePoint | 214 |
| Olema Pharmaceuticals | 137 |
| Cullinan Therapeutics | 109 |
| ORIC Pharmaceuticals | 104 |
| Lexicon Pharmaceuticals | 81 |
ANRO News
- 7 days ago - Alto Neuroscience prices 3.78M shares at $26.48 in registered direct offering - TheFly
- 7 days ago - Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock - Business Wire
- 4 weeks ago - Alto Neuroscience Transcript: 7th Annual HCW Neuro Perspectives Hybrid Conference - Transcripts
- 5 weeks ago - Alto Neuroscience highlights publication in Nature Medicine on Prime-Praxol - TheFly
- 5 weeks ago - Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia - Business Wire
- 5 weeks ago - Alto Neuroscience Slides: Corporate presentation - Filings
- 6 weeks ago - Alto Neuroscience Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Alto Neuroscience appoints Miller to Board of Directors - TheFly